Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery

被引:69
作者
Nordin-Andersson, M
Walum, E
Kjellstrand, P
Forsby, A [1 ]
机构
[1] Stockholm Univ, Dept Neurochem & Neurotoxicol, SE-10691 Stockholm, Sweden
[2] Gambro AB, Dept Res, Lund, Sweden
[3] Biovitrum AB, Dept Biol, Stockholm, Sweden
关键词
acrylamide; calcium; neurotoxicity; recovery; SH-SY5Y;
D O I
10.1023/A:1022017731328
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Basal cytotoxicity, morphological changes and alterations in cell physiological and neurochemical functions were studied in differentiated human neuroblastoma (SH-SY5Y) cells during exposure to acrylamide and during a subsequent recovery period after cessation of exposure. Acrylamide induced a 20% reduction in the number of neurites per cell at 0.21 mmol/L and 20% decrease in the protein synthesis rate at 0.17 mmol/L after 72 h of exposure. Furthermore, the basal level of intracellular calcium concentration ([Ca2+](i)) and receptor-activated (carbachol, 0.1 mmol/L) Ca2+ fluxes increased by 49% and 21%, respectively, at 0.25 mmol/L. These observations were made at noncytotoxic acrylamide concentrations, signifying specific neurotoxic alterations. Forty-eight hours after cessation of acrylamide exposure, the SH-SY5Y cells had recovered, i.e., the number of neurites per cell as well as the basal level of [Ca2+](i) and rate of protein synthesis were comparable to those of control cells. The general calpain inhibitor calpeptin decreased the acrylamide-induced (0.5 mmol/L) neurite degeneration, determined as reduction in number of neurites per cell, from 52% to 17% as compared to control cells, which further supports the hypothesis that an increased [Ca2+](i) plays a significant role for acrylamide-induced axonopathy.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 38 条
[1]
[Anonymous], EXPT CLIN NEUROTOXIC
[2]
ATTERWILL CK, 1994, ATLA-ALTERN LAB ANIM, V22, P350
[3]
BIEDLER JL, 1978, CANCER RES, V38, P3751
[4]
BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, P367
[5]
BOTTENSTEIN J, 1979, P NATL ACAD SCI USA, V76, P517
[7]
CAVANAGH JB, 1964, INT REV EXP PATHOL, V3, P219
[9]
The impact of dose rate on the neurotoxicity of acrylamide: The interaction of administered dose, target tissue concentrations, tissue damage, and functional effects [J].
Crofton, KM ;
Padilla, S ;
Tilson, HA ;
Anthony, DC ;
Raymer, JH ;
MacPhail, RC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 139 (01) :163-176
[10]
Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations [J].
DeJongh, J ;
Nordin-Andersson, M ;
Ploeger, BA ;
Forsby, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1999, 158 (03) :261-268